美股A股
StockGist
Back
8-K2026-05-01· deepseek-chat

BTSG · BrightSpring Health Services, Inc. Common Stock

0001193125-26-198983

SEC filing

Summary

BrightSpring Health Services reported strong Q1 2026 results with revenue up 25.6% and raised full-year 2026 guidance, driven by growth in Pharmacy and Provider Services.

Key takeaways

Full analysis

BrightSpring Health Services reported robust first-quarter 2026 results, with net revenue of $3,614 million, up 25.6% year-over-year, driven by strong performance in both Pharmacy Solutions (revenue +25% to $3,171 million) and Provider Services (revenue +28% to $442 million). Gross profit increased 42.5% to $482 million, and net income surged to $74 million from $9 million in the prior year. Adjusted EBITDA rose 44.8% to $190 million, reflecting margin expansion and operational leverage. The company also completed the divestiture of its Community Living business on March 30, 2026, recording a $31.2 million gain on sale within discontinued operations. Management highlighted the team's commitment to operational best practices and scale, as noted by CEO Jon Rousseau. Looking ahead, BrightSpring raised its full-year 2026 guidance: revenue is now expected between $14,725 million and $15,225 million (14.1%-17.9% growth), and Adjusted EBITDA between $795 million and $825 million (28.7%-33.6% growth). The Amedysis and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026. Additionally, the company completed a secondary offering and a $60 million share repurchase in March 2026. Leverage improved to 2.27x from pro forma 2.60x at year-end 2025. The strong quarterly performance and upward guidance revision signal continued momentum in the company's core businesses.